HScore for Reactive Hemophagocytic Syndrome
ورودیهای بالینی بیمار
پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.
- Very Low Risk0–90
- Low Risk91–168
- Intermediate Risk169–250
- High Risk251–337
The HScore for Reactive Hemophagocytic Syndrome calculates determining thromboembolic risk, heparin-induced thrombocytopenia probability, and bleeding diathesis. Key inputs include known immunosuppression. Scores guide initiating targeted anticoagulation therapy, platelet monitoring, or hematology specialist referral. This standardized assessment improves clinical decision safety and bedside patient management.
Clinical Guidelines & Evidence
Estimates the risk of having reactive hemophagocytic syndrome (RHS) based on clinical, laboratory, and histologic findings. Uses nine variables to provide a probability score ranging from <1% to >99% for RHS diagnosis.
Clinical Indication
The HScore for Reactive Hemophagocytic Syndrome is indicated for bedside clinical practice to support Estimates the risk of having reactive hemophagocytic syndrome (RHS) based on clinical, laboratory, and histologic findings. Uses nine variables to provide a probability score ranging from <1% to >99% for RHS diagnosis.. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.
Target Population
Target population comprises Patients presenting with coagulopathy, thrombocytopenia, venous thromboembolism (DVT/PE), or hematologic neoplasms. Clinical application is indicated across Hematology-oncology services, bone marrow transplant units, anticoagulation clinics, and acute medical wards.
Limitations & Contraindications
Severe thrombocytopenia with concomitant microvascular thrombosis (TTP, HIT, DIC) represents a medical emergency requiring rapid intervention.
Clinical Pearls & Action Plan
Detailed history of heparin exposure, platelet count kinetics, and comprehensive coagulation profiles are vital in consumptive coagulopathies. Guideline pearl: Reactive hemophagocytic syndrome is a life-threatening condition requiring urgent treatment.
HScore = sum of weighted points from 9 variables: immunosuppression (0-18), temperature (0-49), organomegaly (0-38), cytopenias (0-34), triglycerides (0-64), fibrinogen (0-30), ferritin (0-50), AST (0-19), hemophagocytosis (0-35)
Input Parameters
| Name | Type | Required | Description |
|---|---|---|---|
| known_immunosuppression | string | Yes | Patient with known underlying immunosuppression |
| temperature | string | Yes | Temperature category |
| organomegaly | string | Yes | Organomegaly (hepatomegaly or splenomegaly) |
| cytopenias | string | Yes | Number of cytopenias |
| triglycerides | string | Yes | Triglyceride level(mg/dL) |
| fibrinogen | string | Yes | Fibrinogen level(mg/dL) |
| ferritin | string | Yes | Ferritin level(ng/mL) |
| ast_sgot | string | Yes | AST/SGOT level(IU/L) |
| hemophagocytosis | string | Yes | Hemophagocytosis features on bone marrow aspirate |
Score Interpretation & Guidance
| Range | Stage | Description |
|---|---|---|
| 0–90 | Very Low Risk | HScore ≤90 |
| 91–168 | Low Risk | HScore 91-168 |
| 169–250 | Intermediate Risk | HScore 169-250 |
| 251–337 | High Risk | HScore >250 |
Evidence-Based References (EBM)
- Fardet L, Galicier L, Lambotte O, Marzac C, Aumont C, Chahwan D, Coppo P, Hie M. Development and validation of the HScore, a score for the diagnosis of reactive hemophagocytic syndrome. Arthritis Rheumatol. 2014 Sep;66(9):2613-20.
- Debaugnies F, Mahadeb B, Ferster A, Meuleman N, Rozen L, Demulder A, Corazza F. Performances of the HScore in the diagnosis of hemophagocytic lymphohistiocytosis: a multicenter study. J Clin Med. 2021 May 17;10(10):2143.